Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Emerald BioStructures, a provider of collaborative drug discovery services to pharmaceutical companies, biotechnology companies, academic institutions and government facilities, and ChemDiv have entered into a drug discovery and development pact.
Subscribe to our email newsletter
Under the agreement, Emerald and ChemDiv will use their transitional and integrated drug discovery and development platform to support collaborative efforts.
ChemDiv Biology CTO and vice president Ilya Okun said ChemDiv and Emerald capabilities complement each other and bring together a combination of technologies to improve drug discovery and development efforts.
"This collaboration demonstrates the commitment of both companies to further improve customer experiences," Okun said.